PT3921026T - Carotenoides c50 para o tratamento ou a prevenção da náusea - Google Patents
Carotenoides c50 para o tratamento ou a prevenção da náuseaInfo
- Publication number
- PT3921026T PT3921026T PT199143348T PT19914334T PT3921026T PT 3921026 T PT3921026 T PT 3921026T PT 199143348 T PT199143348 T PT 199143348T PT 19914334 T PT19914334 T PT 19914334T PT 3921026 T PT3921026 T PT 3921026T
- Authority
- PT
- Portugal
- Prior art keywords
- carotenoids
- treating
- preventing nausea
- nausea
- preventing
- Prior art date
Links
- 206010028813 Nausea Diseases 0.000 title 1
- 235000021466 carotenoid Nutrition 0.000 title 1
- 150000001747 carotenoids Chemical class 0.000 title 1
- 230000008693 nausea Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P23/00—Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/01—Hydrocarbons
- A61K31/015—Hydrocarbons carbocyclic
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/01—Preparation of mutants without inserting foreign genetic material therein; Screening processes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
- C12N15/77—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora for Corynebacterium; for Brevibacterium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K2035/11—Medicinal preparations comprising living procariotic cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Epidemiology (AREA)
- Plant Pathology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Hospice & Palliative Care (AREA)
- Otolaryngology (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962802398P | 2019-02-07 | 2019-02-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT3921026T true PT3921026T (pt) | 2024-03-22 |
Family
ID=71946373
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT199143348T PT3921026T (pt) | 2019-02-07 | 2019-05-10 | Carotenoides c50 para o tratamento ou a prevenção da náusea |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US11001870B2 (pt) |
| EP (2) | EP4331597A3 (pt) |
| JP (2) | JP2022520762A (pt) |
| KR (1) | KR20210125018A (pt) |
| CN (1) | CN113660980A (pt) |
| AU (1) | AU2019428070A1 (pt) |
| CA (1) | CA3128277A1 (pt) |
| DK (1) | DK3921026T3 (pt) |
| ES (1) | ES2974189T3 (pt) |
| PT (1) | PT3921026T (pt) |
| WO (1) | WO2020162959A1 (pt) |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2229288T3 (es) | 1995-12-22 | 2005-04-16 | Dsm Ip Assets B.V. | Metodos mejorados para transformar cepas de phaffia, cepas de phaffia transformadas asi obtenidas y dna recombinante en dichos metodos. |
| US6197329B1 (en) * | 1999-05-03 | 2001-03-06 | Drugtech Corporation | Anti-nausea compositions and methods |
| CA2386540A1 (en) | 1999-10-04 | 2001-04-12 | University Of Medicine And Dentistry Of New Jersey | Novel carbamates and ureas |
| WO2002041833A2 (en) | 2000-11-22 | 2002-05-30 | Cargill Incorporated | Carotenoid biosynthesis |
| CA2615419A1 (en) * | 2005-07-18 | 2007-01-25 | Basf Aktiengesellschaft | Use of a bacillus meti gene to improve methionine production in microorganisms |
| GB0524873D0 (en) | 2005-12-06 | 2006-01-11 | New Royal Holloway & Bedford | Bacterial production of carotenoids |
| US20100124583A1 (en) * | 2008-04-30 | 2010-05-20 | Xyleco, Inc. | Processing biomass |
| TW200934872A (en) | 2008-02-05 | 2009-08-16 | Echem Hightech Co Ltd | A strain of genetically reengineered escherichia coli for biosynthesis of high yield carotenoids after mutation screening |
| US20090263514A1 (en) * | 2008-04-21 | 2009-10-22 | Govindan Gopinathan | Cold and flu tonic |
| US8637263B1 (en) | 2010-10-14 | 2014-01-28 | Epiomed Therapeutics, Inc. | Assay for determination of compounds having anti-emetic activity |
| US9562220B2 (en) | 2011-06-10 | 2017-02-07 | National University Corporation Chiba University | Method for producing carotenoids each having 50 carbon atoms |
| US10682385B2 (en) | 2014-01-10 | 2020-06-16 | Aftab Ahmad | Saffron treatment method for mammalian maladies |
| ES2758179T3 (es) * | 2014-05-21 | 2020-05-04 | Nestle Sa | Procedimiento para producir una suplementación personalizada de nutrientes |
| EP3037164A1 (en) | 2014-12-23 | 2016-06-29 | Haldor Topsøe A/S | Particle separating catalytic chemical reactor and particle separator |
| US20180296582A1 (en) * | 2015-04-23 | 2018-10-18 | Kaleido Biosciences, Inc. | Microbiome regulators and related uses thereof |
| EP3341408A4 (en) * | 2015-08-27 | 2019-04-24 | The General Hospital Corporation | METHOD AND COMPOSITIONS FOR INHIBITING THE DETOXIFICATION REACTION |
| WO2017187183A1 (en) | 2016-04-27 | 2017-11-02 | Itara Therapeutics | Methods for the identification of bifunctional compounds |
-
2019
- 2019-05-10 DK DK19914334.8T patent/DK3921026T3/da active
- 2019-05-10 PT PT199143348T patent/PT3921026T/pt unknown
- 2019-05-10 ES ES19914334T patent/ES2974189T3/es active Active
- 2019-05-10 US US16/409,546 patent/US11001870B2/en active Active
- 2019-05-10 EP EP23210174.1A patent/EP4331597A3/en active Pending
- 2019-05-10 CN CN201980095134.7A patent/CN113660980A/zh active Pending
- 2019-05-10 EP EP19914334.8A patent/EP3921026B1/en active Active
- 2019-05-10 JP JP2021546255A patent/JP2022520762A/ja active Pending
- 2019-05-10 WO PCT/US2019/031814 patent/WO2020162959A1/en unknown
- 2019-05-10 AU AU2019428070A patent/AU2019428070A1/en active Pending
- 2019-05-10 KR KR1020217027307A patent/KR20210125018A/ko unknown
- 2019-05-10 CA CA3128277A patent/CA3128277A1/en active Pending
-
2021
- 2021-04-12 US US17/228,110 patent/US20210230660A1/en active Pending
-
2023
- 2023-06-01 JP JP2023090609A patent/JP2023110011A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CA3128277A1 (en) | 2020-08-13 |
| EP3921026A4 (en) | 2022-10-19 |
| EP3921026A1 (en) | 2021-12-15 |
| JP2022520762A (ja) | 2022-04-01 |
| US20210230660A1 (en) | 2021-07-29 |
| US11001870B2 (en) | 2021-05-11 |
| EP4331597A2 (en) | 2024-03-06 |
| WO2020162959A1 (en) | 2020-08-13 |
| AU2019428070A1 (en) | 2021-08-19 |
| EP4331597A3 (en) | 2024-05-15 |
| DK3921026T3 (da) | 2024-03-18 |
| EP3921026B1 (en) | 2023-12-20 |
| ES2974189T3 (es) | 2024-06-26 |
| US20200255882A1 (en) | 2020-08-13 |
| JP2023110011A (ja) | 2023-08-08 |
| KR20210125018A (ko) | 2021-10-15 |
| CN113660980A (zh) | 2021-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL285496A (en) | Methods for treating biliary obstruction | |
| EP3638228C0 (en) | COMPOUNDS FOR TREATING TRIPLE NEGATIVE BREAST CANCER | |
| SG11202006893WA (en) | Disrupting the linc complex for treating laminopathy | |
| IL287907A (en) | Cancer treatment methods | |
| EP3892282A4 (en) | COMBINATIONS FOR TREATING CANCER | |
| EP3632431A4 (en) | AGENTS FOR PREVENTING OR TREATING BRAIN ATROPHY | |
| EP3894561A4 (en) | CANCER TREATMENT METHODS | |
| EP3820461A4 (en) | METHODS OF TREATMENT OF CANCER | |
| PL3459543T3 (pl) | Związek karbaminianowy do zapobiegania lub leczenia fibromialgii | |
| EP3752161A4 (en) | FIBROSIS TREATMENT METHODS | |
| EP4054378C0 (en) | COMPOSITIONS FOR HAIR TREATMENT | |
| IL286681A (en) | Compounds and methods for modulating ube3a-ats | |
| GB201909468D0 (en) | Compounds for treating cancer | |
| NO20190133A1 (en) | Fremgangsmåte for inspeksjon av rør | |
| IL290319A (en) | Compound for combined treatment | |
| PT3921026T (pt) | Carotenoides c50 para o tratamento ou a prevenção da náusea | |
| EP3958858A4 (en) | TREATMENT METHODS AGAINST VIRUSES | |
| IL271967A (en) | Methods for treating congenital hypersecretion of insulin | |
| GB201914296D0 (en) | Treatment | |
| GB201909466D0 (en) | Compounds for treating cancer | |
| IL288526A (en) | Therapies based on thiarbine and meters drug thiarbine | |
| EP3863606A4 (en) | METHODS OF TREATMENT OR PREVENTION OF SKIN PROBLEMS | |
| EP3763380A4 (en) | ENCEPHALOPATHY TREATMENT METHOD | |
| EP3849605A4 (en) | METHODS OF TREATMENT OF PANCREATITIS | |
| IL287840A (en) | treatment system |